Dr. van Besien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-553-2797- Is this information wrong?
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1990
- Indiana University School of MedicineResidency, Internal Medicine, 1987 - 1989
- Catholic University of LeuvenClass of 1984
Certifications & Licensure
- OH State Medical License 2022 - 2026
- NY State Medical License 2011 - 2025
- IL State Medical License 1997 - 2014
- TX State Medical License 1992 - 2001
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 154 citationsTemsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II ConsortiumSonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin
Journal of Clinical Oncology. 2010-11-01 - 48 citationsHigh-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.Uday R. Popat, D Przepiork, Richard E. Champlin, William C. Pugh, K. Amin
Journal of Clinical Oncology. 1998-01-01 - 36 citationsRegulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.Maaza G-Amlak, Shahab Uddin, Dolores Mahmud, Ingrid Damacela, Donald Lavelle
Biochemical and Biophysical Research Communications. 2002-10-04
Abstracts/Posters
- Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF AdministrationKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain AmyloidosisKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Inferior Survival with Use of Autologous Stem Cell Transplant As Second-Line Therapy in Multiple MyelomaKoen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Other Languages
- Spanish, French, German, Dutch
Hospital Affiliations
- University Hospitals Cleveland Medical CenterCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: